Work

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Xp13512/Gsk1838262 in the Treatment of Patients With Primary Restless Legs Syndrome

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: SLEEP

DOI: 10.5665/sleep/32.2.159

Authors: Clete A. Kushida, MD, PhD, Arthur S. Walters, MD, Philip Becker, MD, Stephen G. Thein, PhD, A. Thomas Perkins, MD, PhD, Thomas Roth, PhD, Daniel Canafax, PharmD, Ronald W. Barrett, PhD, The XP021 Study Group

Institutions: Stanford University, Seton Hall University, John F. Kennedy Medical Center, Raleigh Neurology Associates, Henry Ford Hospital

Language: English

Topic: Restless Legs Syndrome Research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4244884156

FWCI:

Cites: 11

Cited by:

Related to: 10